{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:11:12Z","timestamp":1793121072378,"version":"4.5.0"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In recent years, the role of gut microbiota and derived metabolites in renal disease has attracted more attention. It has been established that the gut microbiota is a potential target for medical interventions in renal disease including chronic kidney disease (CKD), acute kidney injury (AKI) and renal calculus. Emerging evidence has related dialysis treatment to the microbial composition and function of the intestines, and there are many reports related to HD, but few studies have been related to PD. Previous studies have found that PD patients have intestinal flora disturbances, so we speculate that intestinal flora and its metabolites may be the regulatory factors in long-term therapy of PD. And as far as we know, there have been no studies characterized the gut microbiota in PD patients of different dialysis vintages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>It is a cross-sectional study based on clinical data and biological samples of 72 patients with CAPD, 13 patients with ESRD and 13 healthy volunteers. The intestinal microecological characteristics of CAPD patients were comprehensively evaluated by combining the intestinal microflora structure, enterotoxin and receptor (serum LPS and LBP), intestinal barrier function index (serum D-Lactate), intestinal uremic toxin (serum IS, PCS, TMAO), fecal SCFAs and other multi-dimensional and multi-omics studies. Furthermore, the changes of intestinal microecology in CAPD patients of different dialysis vintages (\u2265 3 and &amp;lt; 12 months, \u2265 12 and &amp;lt; 24 months, \u2265 24 and &amp;lt; 60 months, \u2265 60 months) were further explored, and the correlations between intestinal microecology indicators and some clinical indicators were analyzed. Fecal and serum samples were collected from PD patients (PD group, <jats:italic>n<\/jats:italic> = 72), ESRD patients (ESRD group, <jats:italic>n<\/jats:italic> = 13) and healthy volunteers (Normal group, <jats:italic>n<\/jats:italic> = 13). Fecal samples were subjected to microbiome (16S rDNA) and SCFA (GC-MS) analyses. Serum samples were subjected to LPS, LBP, D-lactate, IS, PCS, and TMAO (ELISA) analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The diversity and richness of intestinal flora in CAPD patients were lower than those in healthy people and ESRD patients, and the microflora structure was different. Anaerobes of Blautia and facultative anaerobes and aerobic bacteria with Bacilli and Lactobacillales those in Firmicutes are the main intestinal flora in CAPD patients. The abundance of Bacteroidaceae, Bacteroides, Faecalibacterium and other dominant bacteria in the intestinal tract of CAPD patients decreased. Proteobacteria, Enterobacteriaceae and Escherichia-Shigella increased their colonization (LDA &amp;gt; 4). In CAPD patients of different dialysis vintages, there was no significant change in the diversity and richness of microflora, and the microflora structure of PDC group was significantly different from that of PDD, which the abnormal expansion of enterobacter group was more prominent in PDC and the abundance of Bacteroides group was relatively higher in PDD. Intestinal barrier damage, intestinal uremic toxin accumulation and short-chain fatty acid reduction were observed in CAPD patients, such as the serum level of D-Lactate, PCS and TMAO were significantly higher than that in the Normal group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05),and the fecal levels of BA and CA were significantly lower (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). The intestinal microecological disorder of PDC group, while that of PDD group showed a better trend. Such as the PDC group had a significantly higher serum level of LPS, D-Lactate and TMAO (<jats:italic>P<\/jats:italic> &amp;lt; 0.01), and significantly lower serum level of LBP (<jats:italic>P<\/jats:italic> &amp;lt; 0.01), and lower fecal levels of AA and BA (<jats:italic>P<\/jats:italic> &amp;gt; 0.05) than the PDD group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The intestinal microecology and metabolic system of CAPD patients had changes compared with healthy people and ESRD non-dialysis patients, and there were differences in CAPD patients with different dialysis vintages. PD patients on dialysis for more than 60 months showed a better trend in the intestinal microecology than patients with 24\u223c36 months, which suggested that the intestinal microecology of PD patients had a certain ability of self-regulation and remodeling under the management of standardized system and it is necessary to strengthen the monitoring of the intestinal status and the occurrence of related complications in PD patients on dialysis of 24\u223c36 months of dialysis vintage. It is initially considered that the mechanism of intestinal microecology is a potential target for intervention in the diagnosis and treatment of CAPD and incorporating intestinal microecosystem monitoring into the long-term management of CAPD patients is a new strategy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1302352","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T05:38:42Z","timestamp":1704433122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages"],"prefix":"10.3389","volume":"10","author":[{"given":"Jiaqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1159\/000508023","article-title":"Telenephrology with remote peritoneal dialysis monitoring during Coronavirus Disease 19.","volume":"51","author":"El Shamy","year":"2020","journal-title":"Am J Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.34067\/kid.0001662020","article-title":"Early use of telehealth in home dialysis during the COVID-19 pandemic in New York City.","volume":"1","author":"Srivatana","year":"2020","journal-title":"Kidney360."},{"key":"B3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","article-title":"Changes in the worldwide epidemiology of peritoneal dialysis.","volume":"13","author":"Li","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","article-title":"Peritoneal dialysis use and practice patterns: an international survey study.","volume":"77","author":"Cho","year":"2021","journal-title":"Am J Kidney Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1319-2442.279927","article-title":"Metabolome and microbiome in kidney diseases.","volume":"31","author":"Vairakkani","year":"2020","journal-title":"Saudi J Kidney Dis Transpl."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.","volume":"17","author":"Chen","year":"2019","journal-title":"J Transl Med."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa166","article-title":"Characterization of gut microbiota composition in hemodialysis patients with normal weight obesity.","volume":"105","author":"Lin","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6739762","article-title":"Effect of different hemodialysis methods on Microbiota in uremic patients.","volume":"2020","author":"He","year":"2020","journal-title":"Biomed Res Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/ndt\/gfaa019","article-title":"Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study.","volume":"36","author":"Lin","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00213-020-05569-x","article-title":"Abnormalities in gut microbiota and serum metabolites in hemodialysis patients with mild cognitive decline: a single-center observational study.","volume":"237","author":"Zhu","year":"2020","journal-title":"Psychopharmacology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/aem.05605-11","article-title":"Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients.","volume":"78","author":"Wang","year":"2012","journal-title":"Appl Environ Microbiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1668-4","article-title":"High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.","volume":"21","author":"Hu","year":"2020","journal-title":"BMC Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/nep.12580","article-title":"Indoxyl sulphate and kidney disease: causes, consequences and interventions.","volume":"21","author":"Ellis","year":"2016","journal-title":"Nephrology."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010114","article-title":"Synbiotics alleviate the gut indole load and dysbiosis in chronic kidney disease.","volume":"10","author":"Yang","year":"2021","journal-title":"Cells."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9020052","article-title":"p-Cresyl sulfate.","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins."},{"key":"B16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/j.jrn.2013.06.003","article-title":"Protein-bound uremic toxins\u2026new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease.","volume":"23","author":"Soulage","year":"2013","journal-title":"J Ren Nutr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","article-title":"The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.","volume":"92","author":"Tomlinson","year":"2017","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/advances\/nmab010","article-title":"Gut microbiota-derived trimethylamine N-oxide and kidney function: a systematic review and meta-analysis.","volume":"12","author":"Zeng","year":"2021","journal-title":"Adv Nutr."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80063-0","article-title":"Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000493862","article-title":"Gut microbial product predicts cardiovascular risk in chronic kidney disease patients.","volume":"48","author":"Jadoon","year":"2018","journal-title":"Am J Nephrol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104359","article-title":"Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome.","volume":"147","author":"Zhang","year":"2020","journal-title":"Microb Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/ijmm.2019.4397","article-title":"Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db\/db mice and HG-induced NRK-52E cells.","volume":"45","author":"Du","year":"2020","journal-title":"Int J Mol Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on \u2018KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u2019.","volume":"84","author":"Andrassy","year":"2013","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0047-6374(90)90108-r","article-title":"Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol.","volume":"55","author":"Ligthart","year":"1990","journal-title":"Mech Ageing Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update.","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies.","volume":"27","author":"Mago\u00e8","year":"2011","journal-title":"Bioinformatics."},{"key":"B27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1101\/gr.112730.110","article-title":"Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons.","volume":"21","author":"Haas","year":"2011","journal-title":"Genome Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.21147\/j.issn.1000-9604.2020.06.09","article-title":"Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma.","volume":"32","author":"Li","year":"2020","journal-title":"Chin J Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/bioinformatics\/btv287","article-title":"Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data.","volume":"31","author":"A\u00dfhauer","year":"2015","journal-title":"Bioinformatics."},{"key":"B30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.foodchem.2011.04.022","article-title":"Development of a headspace solid-phase microextraction gas chromatography\u2013mass spectrometric method for the determination of short-chain fatty acids from intestinal fermentation.","volume":"129","author":"Bianchi","year":"2011","journal-title":"Food Chem."},{"key":"B31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2017.02.016","article-title":"Application of packed-fiber solid-phase extraction coupled with GC-MS for the determination of short-chain fatty acids in children\u2019s urine.","volume":"468","author":"Zhao","year":"2017","journal-title":"Clin Chim Acta."},{"key":"B32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/bmc.580","article-title":"Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography.","volume":"20","author":"Zhao","year":"2006","journal-title":"Biomed Chromatogr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota.","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease.","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016169","article-title":"Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats.","volume":"6","author":"Cinova","year":"2011","journal-title":"PLoS One."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.17219\/acem\/64883","article-title":"Intestinal epithelial barrier: the target for pathogenic Escherichia coli.","volume":"26","author":"Paw\u0142owska","year":"2017","journal-title":"Adv Clin Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.15252\/embr.201439263","article-title":"The composition of the gut microbiota shapes the colon mucus barrier.","volume":"16","author":"Jakobsson","year":"2015","journal-title":"EMBO Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/bj3060225","article-title":"Tissue- and cell-specific expression of mouse xanthine oxidoreductase gene in vivo: regulation by bacterial lipopolysaccharide.","volume":"306","author":"Kurosaki","year":"1995","journal-title":"Biochem J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s0015-6264(66)80583-7","article-title":"Reduction of tartrazine by a Proteus species isolated from rats.","volume":"4","author":"Roxon","year":"1966","journal-title":"Food Cosmet Toxicol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.16519\/j.cnki.1004-311x.2021.06.0095","article-title":"Research progress of pyrimidine metabolism in microbes.","volume":"31","author":"Zhang","year":"2021","journal-title":"Biotechnology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1128\/br.40.2.403-468.1976","article-title":"Degradation of purines and pyrimidines by microorganisms.","volume":"40","author":"Vogels","year":"1976","journal-title":"Bacteriol Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbiotec.2019.01.013","article-title":"Engineering Escherichia coli for respiro-fermentative production of pyruvate from glucose under anoxic conditions.","volume":"293","author":"Skorokhodova","year":"2019","journal-title":"J Biotechnol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02989","article-title":"Gut microbiome as a potential factor for modulating resistance to cancer immunotherapy.","volume":"10","author":"Shui","year":"2019","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canlet.2017.11.036","article-title":"Interplay between the lung microbiome and lung cancer.","volume":"415","author":"Mao","year":"2018","journal-title":"Cancer Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1126\/science.aaf3951","article-title":"Cospeciation of gut microbiota with hominids.","volume":"353","author":"Moeller","year":"2016","journal-title":"Science."},{"key":"B46","first-page":"933","article-title":"Research progress of endotoxin\/lipopolysaccharide binding proteins and bactericidal permeability increasing proteins.","volume":"35","author":"Zheng","year":"2007","journal-title":"Clin J Med Offic."},{"key":"B47","first-page":"S5","article-title":"Atlas of peritoneal histology.","volume":"20","author":"Di Paolo","year":"2000","journal-title":"Perit Dial Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1523-1755.2002.00143.x","article-title":"Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells.","volume":"61","author":"Mandl-Weber","year":"2002","journal-title":"Kidney Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2337\/dc10-0340","article-title":"A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.","volume":"33","author":"Sun","year":"2010","journal-title":"Diabetes Care."},{"key":"B50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2013.07.004","article-title":"Serum lipopolysaccharide-binding protein as a marker of atherosclerosis.","volume":"230","author":"Serrano","year":"2013","journal-title":"Atherosclerosis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.apsb.2016.03.009","article-title":"Parishin C\u2019s prevention of A\u03b2 1-42-induced inhibition of long-term potentiation is related to NMDA receptors.","volume":"6","author":"Liu","year":"2016","journal-title":"Acta Pharm Sin B."},{"key":"B52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08941930390215033","article-title":"Plasma D-lactate levels in diagnosis of appendicitis.","volume":"16","author":"Ca\u011flayan","year":"2003","journal-title":"J Invest Surg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.34067\/kid.0000132021","article-title":"The gut and blood microbiome in IgA nephropathy and healthy controls.","volume":"2","author":"Shah","year":"2021","journal-title":"Kidney360."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s11255-018-1873-2","article-title":"The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.","volume":"50","author":"Kanbay","year":"2018","journal-title":"Int Urol Nephrol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1053\/j.ajkd.2007.12.035","article-title":"A review of albumin binding in CKD.","volume":"51","author":"Meijers","year":"2008","journal-title":"Am J Kidney Dis."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144410","article-title":"Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.","volume":"6","author":"Chaves","year":"2021","journal-title":"JCI Insight."},{"key":"B57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1681\/asn.2014111063","article-title":"Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden.","volume":"27","author":"Stubbs","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8110326","article-title":"Trimethylamine N-oxide: the good, the bad and the unknown.","volume":"8","author":"Velasquez","year":"2016","journal-title":"Toxins."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01387-y","article-title":"Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/dc19-0048","article-title":"Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes.","volume":"42","author":"Winther","year":"2019","journal-title":"Diabetes Care."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2015.00095","article-title":"Serum concentrations of p-Cresyl sulfate and Indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.","volume":"35","author":"Viaene","year":"2015","journal-title":"Perit Dial Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/nu5041417","article-title":"Fiber and prebiotics: mechanisms and health benefits.","volume":"5","author":"Slavin","year":"2013","journal-title":"Nutrients."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00185","article-title":"Intestinal short chain fatty acids and their link with diet and human health.","volume":"7","author":"R\u00edos-Covi\u00e1n","year":"2016","journal-title":"Front Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","article-title":"Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.","volume":"52","author":"Sun","year":"2017","journal-title":"J Gastroenterol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1042\/cs20190171","article-title":"Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease.","volume":"133","author":"Wang","year":"2019","journal-title":"Clin Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes."},{"key":"B68","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.1016\/j.dsx.2017.03.006","article-title":"Signaling pathways linking inflammation to insulin resistance.","volume":"11","author":"Zand","year":"2017","journal-title":"Diabetes Metab Syndr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","article-title":"Intestinal Microbiota in cardiovascular health and disease: JACC state-of-the-art review.","volume":"73","author":"Tang","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02800","article-title":"Honokiol ameliorates high-fat-diet-induced obesity of different sexes of mice by modulating the composition of the gut Microbiota.","volume":"10","author":"Ding","year":"2019","journal-title":"Front Immunol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/srep37589","article-title":"Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut Microbiota.","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010051","article-title":"Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and Cardiometabolic disease risk factors.","volume":"11","author":"de la Cuesta-Zuluaga","year":"2018","journal-title":"Nutrients"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1302352\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T05:39:03Z","timestamp":1704433143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1302352\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":72,"alternative-id":["10.3389\/fmed.2023.1302352"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1302352","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"article-number":"1302352"}}